[Comparative bacteriological investigations with the combination trimethoprim/sulfamethoxazole in vitro and in vivo].
D000362:Agar; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003470:Culture Media; D004352:Drug Resistance, Microbial; D004357:Drug Synergism; D004755:Enterobacteriaceae / Q000187:drug effects*; D004756:Enterobacteriaceae Infections / Q000188:drug therapy*; D004927:Escherichia coli Infections / Q000188:drug therapy; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D006192:Haemophilus Infections / Q000188:drug therapy; D008589:Meningococcal Infections / Q000188:drug therapy; D051379:Mice; D008826:Microbial Sensitivity Tests; D011008:Pneumococcal Infections / Q000188:drug therapy; D011743:Pyrimidines / Q000627:therapeutic use*; D013290:Streptococcal Infections / Q000188:drug therapy; D013420:Sulfamethoxazole / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D003470:Culture Media; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D000362:Agar; D013420:Sulfamethoxazole
Vergleichende bakteriologische Untersuchungen mit der Kombination Trimethoprim/Sulfamethoxazol in vitro und in vivo.